EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

Clinical trial NCT06802835 · RECRUITING

Trial details

NCT number: NCT06802835
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Cancinoma (NPC)Recurrent Nasopharynx Carcinoma Metastatic Nasopharyngeal Carcinoma

Start date: 2025-07-09
Primary completion: 2027-06-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.